Immunome - M&A Summary and Business Overview

Life ScienceCompany

Immunome M&A Summary

Immunome has acquired 3 companies, including 3 in the last 5 years.

Immunome’s largest acquisition to date was in 2023, when it acquired Atreca - Antibody s Related Assets and Materials for $6M. Immunome has acquired in 3 different US states. The Company’s most targeted sectors include life science (100%).

Immunome Business Overview

Where is Immunome headquartered?

Immunome is headquartered in Exton, Pennsylvania.

How many employees does Immunome have?

Immunome has 39 employees.

What sector is Immunome in?

Immunome is a life science company.

When was Immunome founded?

Immunome was founded in 2006.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2
  • M&A Advisors 2

Immunome

Immunome, Inc.

665 Stockton Drive, Suite 300,
Exton, Pennsylvania 19341
United States,
(610) 321-3700
www.immunome.com

Immunome is a biopharmaceutical company utilizing its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. Immunome was founded in 2006 and is based in Exton, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # - - - - 2 1 3
vol $6M $6M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Ayala Pharmaceuticals - AL102 2024-02-06 - Divestiture
Rehovot, Pennsylvania
Atreca - Antibody's Related Assets and Materials 2023-12-26 6M USD Divestiture
, United States
MorphImmune 2023-06-29 - Merger
West Lafayette, Indiana · www.morphimmune.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 6M (100%) - -
Total 3 $6M - -

By Geo

State/Country Buy Value Sell Value
United States 3 6M - -
  Pennsylvania 1 - - -
  Indiana 1 - - -
Total 3 $6M - -

Top M&A Advisors

Financial Deals
Stifel, Nicolaus & Co., Inc.
1
Legal Deals
Mintz Levin Cohn Ferris Glovsky and Popeo PC
1

Deal Values

buy # Total
< $100M 1 $6M
TOTAL $6M
Largest Atreca - Antibody's Related Assets and Materials
$6M (2023-12-26)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.